159 related articles for article (PubMed ID: 25255441)
1. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
[TBL] [Abstract][Full Text] [Related]
2. Vorinostat in the acute neuroinflammatory form of X-linked adrenoleukodystrophy.
Zierfuss B; Weinhofer I; Kühl JS; Köhler W; Bley A; Zauner K; Binder J; Martinović K; Seiser C; Hertzberg C; Kemp S; Egger G; Leitner G; Bauer J; Wiesinger C; Kunze M; Forss-Petter S; Berger J
Ann Clin Transl Neurol; 2020 May; 7(5):639-652. PubMed ID: 32359032
[TBL] [Abstract][Full Text] [Related]
3. ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapy.
Park CY; Kim HS; Jang J; Lee H; Lee JS; Yoo JE; Lee DR; Kim DW
PLoS One; 2013; 8(2):e56242. PubMed ID: 23437103
[TBL] [Abstract][Full Text] [Related]
4. Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.
Corzo D; Gibson W; Johnson K; Mitchell G; LePage G; Cox GF; Casey R; Zeiss C; Tyson H; Cutting GR; Raymond GV; Smith KD; Watkins PA; Moser AB; Moser HW; Steinberg SJ
Am J Hum Genet; 2002 Jun; 70(6):1520-31. PubMed ID: 11992258
[TBL] [Abstract][Full Text] [Related]
5. Beneficial Effects of the Direct AMP-Kinase Activator PXL770 in In Vitro and In Vivo Models of X-Linked Adrenoleukodystrophy.
Monternier PA; Parasar P; Theurey P; Gluais Dagorn P; Kaur N; Nagaraja TN; Fouqueray P; Bolze S; Moller DE; Singh J; Hallakou-Bozec S
J Pharmacol Exp Ther; 2022 Aug; 382(2):208-222. PubMed ID: 35764327
[TBL] [Abstract][Full Text] [Related]
6. Increased neurotoxicity of high-density lipoprotein secreted from murine reactive astrocytes deficient in a peroxisomal very-long-chain fatty acid transporter Abcd1.
Fujitani N; Akashi T; Saito M; Morita M; So T; Oka K
J Inherit Metab Dis; 2024 Mar; 47(2):289-301. PubMed ID: 38146202
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome Metabolism Contributes to PIEZO2-Mediated Mechanical Allodynia.
Gong Y; Laheji F; Berenson A; Qian A; Park SO; Kok R; Selig M; Hahn R; Sadjadi R; Kemp S; Eichler F
Cells; 2022 Jun; 11(11):. PubMed ID: 35681537
[TBL] [Abstract][Full Text] [Related]
8. Peroxisomal very long-chain fatty acid transport is targeted by herpesviruses and the antiviral host response.
Weinhofer I; Buda A; Kunze M; Palfi Z; Traunfellner M; Hesse S; Villoria-Gonzalez A; Hofmann J; Hametner S; Regelsberger G; Moser AB; Eichler F; Kemp S; Bauer J; Kühl JS; Forss-Petter S; Berger J
Commun Biol; 2022 Sep; 5(1):944. PubMed ID: 36085307
[TBL] [Abstract][Full Text] [Related]
9. X-linked adrenoleukodystrophy: molecular and functional analysis of the ABCD1 gene in Argentinean patients.
Amorosi CA; Myskóva H; Monti MR; Argaraña CE; Morita M; Kemp S; Dodelson de Kremer R; Dvoráková L; Oller de Ramírez AM
PLoS One; 2012; 7(12):e52635. PubMed ID: 23300730
[TBL] [Abstract][Full Text] [Related]
10. Role of Basal Forebrain Neurons in Adrenomyeloneuropathy in Mice and Humans.
Gong Y; Laheji F; Berenson A; Li Y; Moser A; Qian A; Frosch M; Sadjadi R; Hahn R; Maguire CA; Eichler F
Ann Neurol; 2024 Mar; 95(3):442-458. PubMed ID: 38062617
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiling identifies novel mutations and SNPs in ABCD1 gene: a molecular, biochemical and clinical analysis of X-ALD cases in India.
Kumar N; Taneja KK; Kalra V; Behari M; Aneja S; Bansal SK
PLoS One; 2011; 6(9):e25094. PubMed ID: 21966424
[TBL] [Abstract][Full Text] [Related]
12. Adrenomyeloneuropathy with Later Development of Cerebral Form Caused by a Hemizygous Splice-site Variant in ABCD1.
Takegami N; Matsukawa T; Hamada M; Tanifuji S; Tamura T; Yamaguchi-Takegami N; Ishiura H; Mitsui J; Sakuishi K; Tsuji S; Toda T
Intern Med; 2024 Apr; 63(7):999-1004. PubMed ID: 37558478
[TBL] [Abstract][Full Text] [Related]
13. The absence of ABCD2 sensitizes mice to disruptions in lipid metabolism by dietary erucic acid.
Liu J; Liang S; Liu X; Brown JA; Newman KE; Sunkara M; Morris AJ; Bhatnagar S; Li X; Pujol A; Graf GA
J Lipid Res; 2012 Jun; 53(6):1071-9. PubMed ID: 22493092
[TBL] [Abstract][Full Text] [Related]
14. Etiology and treatment of adrenoleukodystrophy: new insights from
Gordon HB; Valdez L; Letsou A
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29739804
[TBL] [Abstract][Full Text] [Related]
15. Imbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy.
Launay N; Lopez-Erauskin J; Bianchi P; Guha S; Parameswaran J; Coppa A; Torreni L; Schlüter A; Fourcade S; Paredes-Fuentes AJ; Artuch R; Casasnovas C; Ruiz M; Pujol A
Brain; 2024 Jun; 147(6):2069-2084. PubMed ID: 38763511
[TBL] [Abstract][Full Text] [Related]
16. Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia.
He Y; Phan K; Bhatia S; Pickford R; Fu Y; Yang Y; Hodges JR; Piguet O; Halliday GM; Kim WS
Sci Rep; 2021 Nov; 11(1):21348. PubMed ID: 34725421
[TBL] [Abstract][Full Text] [Related]
17. Low donor chimerism may be sufficient to prevent demyelination in adrenoleukodystrophy.
Ikeda T; Kawahara Y; Miyauchi A; Niijima H; Furukawa R; Shimozawa N; Morimoto A; Osaka H; Yamagata T
JIMD Rep; 2022 Jan; 63(1):19-24. PubMed ID: 35028267
[TBL] [Abstract][Full Text] [Related]
18. Generating human AMN and cALD iPSC-derived astrocytes with potential for modeling X-linked adrenoleukodystrophy phenotypes.
Kaur N; Singh J
bioRxiv; 2024 Jun; ():. PubMed ID: 38854155
[TBL] [Abstract][Full Text] [Related]
19. A novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis.
Hashemi E; Narain Srivastava I; Aguirre A; Tilahan Yoseph E; Kaushal E; Awani A; Kyu Ryu J; Akassoglou K; Talebian S; Chu P; Pisani L; Musolino P; Steinman L; Doyle K; Robinson WH; Sharpe O; Cayrol R; Orchard P; Lund T; Vogel H; Lenail M; Han MH; Bonkowsky JL; Van Haren KP
bioRxiv; 2023 Nov; ():. PubMed ID: 37986739
[TBL] [Abstract][Full Text] [Related]
20. Ataxia with giant axonopathy in Acbd5-deficient mice halted by adeno-associated virus gene therapy.
Granadeiro L; Zarralanga VE; Rosa R; Franquinho F; Lamas S; Brites P
Brain; 2024 Apr; 147(4):1457-1473. PubMed ID: 38066620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
